2Y00
TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND PARTIAL AGONIST DOBUTAMINE (CRYSTAL DOB92)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2009-11-26 |
Detector | MARMOSAIC 225 mm CCD |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 90.000, 60.500, 101.900 |
Unit cell angles | 90.00, 110.20, 90.00 |
Refinement procedure
Resolution | 95.650 - 2.500 |
R-factor | 0.22792 |
Rwork | 0.226 |
R-free | 0.25551 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2vt4 |
RMSD bond length | 0.014 |
RMSD bond angle | 1.473 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.700 | 2.640 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.150 | 0.510 |
Number of reflections | 33665 | |
<I/σ(I)> | 6.2 | 1.9 |
Completeness [%] | 93.8 | 82.8 |
Redundancy | 2.9 | 2.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 277 | SITTING DROP VAPOUR DIFFUSION, PROTEIN (14.5MG/ML) IN 100MM NACL, 0.1MM EDTA, 1.0MM (R, S)-DOBUTAMINE, 1.3MG/ML CHS, 0.55% HEGA-10, 0.1M TRIS-HCL PH8.5, 25% PEG600 AT 4 DEGREES C |